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Abstract 
Objective: This study goal was to screen participants from different settings in Baghdad for depression using Beck Depression Inventory 
(BDI) scale and identify factors influencing the levels of depression. 
Methods: This cross-sectional study included a convenience sample of 313 people from four settings (teaching hospital, college of 
medicine, college of pharmacy, and high school) in Baghdad, Iraq. The participants were screened using paper survey relying on the 
BDI scale during spring 2018. Using multiple linear regression analysis, we measured the association between depression scores and 
six participant factors. 
Results: The overall prevalence of depression in our sample was 57.2%. Female participants had higher BDI scores (depression 
symptoms) than male participants.  Among those with depression, the majority (73.7%) had mild or moderate degree of depression. In 
terms of the cut-off scores, 42.8 % scored in the normal range, 20.4 % in the mild range, 7.0 % in the borderline range, 14.7 % in the 
moderate range, 10.5 % in the severe range and 4.5 % in the very severe range depression. Approximately 63% of the participants had 
sort of suicidal thoughts. The regression analysis showed significant (P-value < 0.05) association between having higher scores of 
depression symptoms and the presence of chronic disease(s), recent family loss, young age and female gender.  
Conclusions: In our findings, depression was quite prevalent among people in Iraq.  The study demonstrates the importance of broad 
screening and social/psychiatric counseling of young population . Iraqi healthcare professionals should structure specific actions for 
patients with chronic diseases to minimize their depression symptoms. 
 
 
Introduction  
The high and increasing prevalence of depression in 
populations in all continents and its serious impacts make it 
one of the most serious public health problems of the 
beginning of the 21st century.  According to the World Health 
Organization (WHO), depression is characterized by “sadness, 
loss of interest or pleasure, feelings of guilt or low self-worth, 
disturbed sleep or appetite, feelings of tiredness, and poor 
concentration”(1). In 2015, there were 322 million people 
living with depression and that represent 4.4% of the global 
population (1). Depression is primary risk factor for suicide (1). 
People with depression experience higher health 
expenditures, work disability and substantial functional 
impairment, (2)  lower adherence to prescribed medications 
and higher risk of mortality after heart surgery (3). 
 
Depression is associated with chronic diseases and can 
increase the risks of developing them (4). In addition, people 
with chronic diseases can experience limitations in their daily 
life that increase their probability of having depression (5).  A 
meta-analysis of 42 studies found association between 
depression,  hyperglycemia and diabetic complications (6). 
Chronic medical illnesses are consistently associated  
with increased prevalence of depression (7).  Sometimes,  
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depression may be due to the specific biologic effects of 
chronic diseases such as central nervous system disorders, 
cerebrovascular disease, and endocrine disorders (8). On the 
other hand, a German study conducted in 20 general practices 
found an association between different chronic diseases and 
lower health-related quality of life (HRQoL) (9). Similarly, a 
survey of 1000 patients found a positive association between 
mood disorder and low health-related quality of life (HRQL) 
(10). The result of a population-based study has shown strong 
association between depression and mortality resulting from 
cardiovascular disease. It reported the probability of dying 
among depressed patients was more than three times higher 
after myocardial infarction than non-depressed patients (11). 
Another meta-analysis of 27 studies found positive significant 
association between depression and diabetes complications 
including retinopathy, nephropathy, neuropathy, sexual 
dysfunction and macrovascular (cardiovascular) complications 
(12). Depression is clearly associated with poorer prognosis 
and more rapid progression of chronic illnesses, including 
ischemic heart disease and diabetes (11, 13).      
   
A large number of Iraqis have been diagnosed with multiple 
illnesses for more than three decades of wars and economic 
sanction, but limited studies are available to quantify the 
prevalence of depression and the relationship between 
chronic illnesses and depression. The objective of this study 
was to screen participants from different settings in Baghdad 
for depression using Beck Depression Inventory scale (BDI) and 
identify factors influencing the levels of the depression. 
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Methods 
A cross-sectional study was carried out between February 1 
and May 1, 2018 in Baghdad, Iraq on a convenience sample 
from college students (college of pharmacy and college of 
medicine), high school students and patients at a public 
teaching hospital. The participants aged 17 years and above. 
After obtaining verbal consent, participants were 
administered a paper survey in-person. The study objectives 
were explained to the participants before beginning the study. 
The survey was completely optional and confidential 
(anonymous). To include illiterate participants in this study, 
two well-trained researchers (last-year pharmacy students) 
administered the survey in Arabic and recorded the participant 
responses.  The paper survey included the Beck Depression 
Inventory Scale (BDI) items and questions regarding the 
participant’s age, gender, marital status, chronic diseases, 
recent loss one of family members and life condition. The 
study proposal was approved by the ethical committee at Al-
Rafidian University Department of Pharmacy, Baghdad. 
 
Study Tool 
Screening for depression was conducted using a validated 
Arabic version of the BDI scale (14, 15). It includes 21-items 
and is commonly used screening tool for assessing depression 
symptoms. The BDI scale can be used to assess normal adults, 
adolescents, and people with mental illnesses. It was 
developed to document a variety of depressive symptoms 
experienced over the preceding week. Responses to the 21 
items of the BDI are on a 4-point scale, ranging from 0 to 3 (16). 
Scores between 1 and 10 are within the range of normal; 11-
16 indicate mild mood disturbance; 17-20 suggest symptoms 
of borderline clinical depression; 21-30 suggest moderate 
depression; 31-40 indicate severe depression; scores over 40 
suggest symptoms consistent with extreme depression (14).  
 
Statistical Analyses 
Means, ranges, standard deviations (SD), frequencies and 
percentages of participant characteristics and BDI items were 
calculated. The data analyses were performed utilizing the 
Statistical Package for the Social Sciences ( SPSS) (IBM,USA) 
Program for Windows, version 22.0. Multiple linear regression 
analysis was used to measure the relationship between the 
independent factors (age, gender, education level, family 
member loss and experiencing chronic disease(s)) and the 
outcome variable (depression score). The statistically 
significant value was p<0.05. 
 
 
 
 
 
 
 
 
 
Results  
Of the 313 people who participated in this study, 147 (47 %) 
were men and 166 (53 %) were women (Table 1). 
Approximately two-third (63.6 %) of the participants were 
patients from a teaching hospital, while 29.7 % were college 
students and 6.7 % were high school students. The study 
population were relatively young people (37.7 years). 
According to the BDI, more than half (57.2 %) of the 
participants reported some level of depression symptoms. In 
terms of the cut-off scores, 134 (42.8 %) scored in the normal 
range (1-10), 64 (20.4 %) in the mild range (11-16), 22 (7.0 %) 
in the borderline range, 46 (14.7 %) in the moderate range (17-
30), 33 (10.5 %) in the severe range (30-40) and 14 (4.5 %) in 
the very severe range (>40) depression. Among those with 
depression symptoms (N=179), the majority (73.7 %) had mild, 
borderline or moderate degrees of depression symptoms 
(Table 1). 
 
 The study showed that 54.8 % (N=98) of the participants with 
depression symptoms were women and 45.2 % (N=81) were 
men . After taking the mean of responses for each of the 21 
items, the results were less than one (range was 0 to 3) which 
mean the participants had lower scores of depression 
symptoms. Three items had the highest score means of 
depression symptoms including worthlessness (0.93), loss of 
interest (0.91) and suicidal thoughts or wishes (0.91). Mild 
suicidal thoughts like “I have thoughts of killing myself, but I 
would not carry them out” were confirmed by 42.8% of 
participants. One-fifth (20.4%) of the participants had 
moderate or severe suicidal thoughts such as “I would like to 
kill myself”;” I would kill myself if I had the chance”. In contrast, 
sadness symptom had the lowest score mean (0.69) among the 
21 items of the BDI (Table 2). 
 
Approximately half (47%) of the participants had one or more 
chronic disease(s) including anxiety, cardiovascular diseases, 
diabetes, chronic renal failure, chronic eye problems, arthritis, 
osteoporosis, obesity and chronic gastrointestinal problems 
(Table 1). 
 
According to the multiple linear regression analysis, there was 
a significant (P-value < 0.05) positive association between the 
presence of a chronic disease and higher scores on the Beck 
Depression Inventory scale. There was significant (P-value < 
0.05) negative association between age and symptoms of 
depression (i.e. the participants with younger age had higher 
risk of depression). There was a significant association 
between gender and depression symptoms (female 
participants had higher BDI scores than male participants). 
Finally, the participants with recent family member loss were 
more likely to experience depression symptoms (Table 3). 
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Table 1: The participant characteristics and  
their level of depression 
Characteristics  Frequency (N) Percent 
Gender 
            Male 147 47 
            Female 166 53 
            Total 313 100 
Education 
   Illiterate 44 14.1 
   Primary School 7 2.2 
   Middle School 46 14.7 
   High School 94 30 
   College degree or higher 122 39 
With Recent Family Loss 22 7 
With Chronic disease(s)* 147 47 
Marital Status 
   Married/engaged 146 46.6 
   Single 167 53.4 
Depression level 
   Normal 134 42.8 
   Mild Mood Disturbance 64 20.4 
   Borderline Depression 22 7.0 
   Moderate Depression 46 14.7 
   Severe Depression 33 10.5 
   Extreme Depression 14 
 
4.5 
Age (years)  37.7 (mean) 15.9 (ST Dev) 
Total N=313, *Chronic diseases included anxiety, cardiovascular 
diseases, renal failure, chronic eye problems, arthritis, osteoporosis, 
obesity and chronic gastrointestinal problems. 
Table 2: The participants’ score means of Beck’s  
Depression Inventory item 
Depression Symptom Mean 
Sadness .69 
Pessimism .83 
Past failure   .87 
Loss of Pleasure  .83 
Guilty Feeling .90 
punishment Feelings  .81 
Self – Dislike .88 
Self – Criticalness .84 
Suicidal Thoughts or Wishes .91* 
Crying .88 
Agitation    .88 
Loss of interest .91* 
Indecisiveness .90 
Worthlessness .93* 
Loss of Energy .89 
Changes in Sleeping Pattern .87 
Irritability .89 
Changes in Appetite .86 
Concentration Difficulty .78 
Tiredness or Fatigue .74 
Loss of interest in Sex .74 
Responses to the BDI items are on a 4-point scale: 0 = no symptoms, 
1=mild symptoms, 2 = moderate symptoms and 3 = severe 
symptoms. *Three items with highest means. 
 
 
 
 
 
 
 
 
 
 
 
Table 3: The multiple linear regression analysis of factors influencing the level of depression 
Factors 
Standardized 
Coefficients 
P-value 
95.0% Confidence Interval for Beta 
Beta Lower Bound Upper Bound 
 Chronic disease .407  .0001* 6.728 10.946 
 Family Loss .282  .0001* 7.957 15.965 
 Marital .055  .274 -.948 3.330 
 Education -.061  .209 -1.248 .275 
 Age -.302  .004* -.345 -.068 
 Gender .367  .0001* 3.555 12.396 
*Significant (P-value < 0.05). R-square=0.306. Outcome variable=depression score.  
Predictors: Gender, Chronic disease, Family Loss, Education level, Marital status, age, gender= male is the reference group. 
 
 
 
 
 
Original Research PRACTICE-BASED RESEARCH 
 
http://z.umn.edu/INNOVATIONS                         2019, Vol. 10, No. 3, Article 6                        INNOVATIONS in pharmacy 
                                                                             DOI: https://doi.org/10.24926/iip.v10i3.2036 
4 
 
Discussion  
This competitive era has amplified the risk of developing 
various mental disorders like depression. In the present study, 
the BDI scale was used to detect the prevalence of depression 
and its associated factors among people in Baghdad. Although 
the BDI is not designed for diagnostic purposes, its 
epidemiologic utility has been evaluated in several studies 
which concluded that it is a reliable and valid indicator of 
depressive disorders in general population (17-19). This survey 
is not a diagnostic test for depression; it is simply a tool that 
can measure the severity of potential symptoms of depression. 
The participants’ scores are to measure symptoms of 
depression or the risk of depression rather than depression 
itself. An actual diagnosis of depression requires a full 
assessment by a physician or psychiatrist. Moderately 
depressed patients may need a combination of medication and 
psychotherapy. Patients with severe depression may not 
respond to psychotherapy, and they are at higher risk for 
suicide (20). 
   
The study participants were relatively young people (37.7 
years). The prevalence of depression symptoms was lower 
among male participants than female participants probably 
because Iraqi culture is a typical Arabic culture, which is male 
dominant.  Arabic cultures impose more limitations on 
women’s behaviors compared to men that may increase 
depression and daily stress among women.  
 
The prevalence of depression symptoms in the whole sample 
was 57.2 %, and 47% of the participants had one or more 
chronic disease(s) such as diabetes, arthritis and asthma and 
cardiovascular diseases (Table 1). More than quarter of the 
participants were pharmacy and medical students who may 
experience high stress during their study-course. Since this 
study found suicidal thoughts among the young participants 
(college and high school students), we recommend providing 
social counselling services at schools and colleges to help those 
students to overcome suicidal thoughts. 
 
Iraqis in general experience high rate of depression because of 
the wars, violence and economic difficulties which they have 
been facing for around four decades. Since 10.5 % and 4.5 % of 
the study, participants had depression of severe and very 
severe grade respectively; we suggest providing group 
counseling facilities within the community. Participants with 
chronic disease(s) had a higher significantly prevalence of 
depression than those without chronic disease even after 
adjusting for demographic and socioeconomic variables (Table 
3). This may be because chronic diseases such as diabetes need 
life-long treatment and follow-up doctor visits, cause 
complications and may cause disability. Similarly, a Korean 
study of depression using the BDI found the participants with 
chronic obstructive pulmonary disease (COPD) (chronic 
disease) had a higher prevalence of depression than a control 
group (21).  This result is consistent with the literature (22).  
There is evidence that patients with chronic respiratory and 
cardiovascular diseases have higher rates of depression (9, 21, 
22) , but some studies have not adequately controlled for 
influence of possible confounders (21).   
 
A study in the U.S. also using the BDI found a positive 
relationship between depressive episodes and post myocardial 
infarction (MI) death which is associated with a decrease in the 
heart rate (23).  Depression can cause insomnia and shorter 
sleep duration, which act as modulators of hypertension 
through increasing activity of the hypothalamic–pituitary–
adrenal axis (24).  A study of 20 general practices in Germany 
showed patients with different chronic diseases have lower 
quality of life and are more likely to experience depression (9). 
A meta-analysis found that depression is associated with 
several complications in patients with diabetes including 
retinopathy, neuropathy, nephropathy, sexual dysfunction 
and macrovascular complications (12). According to a 
literature review of nine depression-related studies, 
depression is associated with several negative consequences 
for diabetic patients such as lower adherence to drug therapy 
and healthy diets, lower quality of life and higher healthcare 
expenses (13). In conclusion, there is positive association 
between depression and chronic diseases and the evidence 
that people with depression experience poor outcomes for 
these diseases.    
 
 Whether people with depression have higher probability of 
developing chronic diseases or people with chronic diseases 
have higher prevalence of depression, it is essential that 
healthcare providers adopt specific policies and actions for this 
population to minimize depression symptoms. According to a 
randomized controlled trial in the U.S., a nurse-led 
intervention of telephonic cognitive behavioral therapy which 
targeted 291 patients with depression and diabetes for three 
months resulted in reduction of depression symptoms (25). An 
American study among health-related colleges in the United 
States found around 20% of the students experience social 
isolation which may lead to depression (26). A cluster 
randomized trial in Netherlands showed that both depression 
care program and proper follow-up visits by primary care 
professionals seem to lead to reduction in depression scale 
among patients with major depression (27). As 
recommendations, the BDI scale is helpful tool to screen 
depression symptoms and Iraqi universities need social 
counseling services to support students who experience 
psychological difficulties for various reasons. As a limitation, 
the study sample size was relatively small and may not 
represent Iraqi population. 
 
Conclusions   
Depression has taken major bulk of medical and pharmacy 
students in its clutches. Having high score of depression 
symptoms are associated with chronic diseases, recent family 
loss, female gender and young age. The study findings 
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demonstrate the importance of screening of young population 
using a simple tool as the BDI. Health professionals, health 
officials, and policy makers must develop specific strategies for 
this vulnerable group. It is critical to recommend appropriate 
interventional measures to prevent the complications of 
depression including suicides.  On an individual, community, 
and national level, it is time to educate Iraqis about depression 
and support those who are suffering from this disorder in 
addition to developing group counseling facilities in large 
cities. We also recommend providing social counselling 
services at schools and universities to help students to 
overcome suicidal thoughts.  Finally, Iraqi healthcare 
professionals should structure specific policies and actions for 
patients with chronic diseases to minimize their depression 
symptoms. 
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